Toggle navigation
Home
Search
Services
Blog
Contact
About
Metabotropic Gluamate Receptor Gene
Vetter, Douglas E.
Salk Institute for Biological Studies, La Jolla, CA, United States
Search 9 grants from Douglas Vetter
Search grants from Salk Institute for Biological Studies
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Exploring genomic determinants of periodontal disease via shared genetic pathways with cardiovascular disease, diabetes, and bone density
Cell Cycle and Sporulation in Bacillis Subtillis
Longitudinal Assessment of the Effects of Hip Arthroscopy on Articular Cartilage Biochemistry through a Novel Quantitative MRI-Based Approach
Cancer and Leukemia Group B
Functional Assay for Regulatory DNA Sequences
Recently added grants:
Technologies for Solid-State NMR Data Collection
Integrated NMR for Complex Systems
Driving Biomedical Projects
Community Engagement
The Global Alliance for Genomics and Health: Setting the Standards for Genomics and Health-Related Data Sharing
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32NS009226-02
Application #
2261011
Study Section
Biological Sciences 2 (BIOL)
Project Start
1995-02-01
Project End
Budget Start
1995-02-01
Budget End
1996-01-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Related projects
NIH 1995
F32 NS
Metabotropic Gluamate Receptor Gene
Vetter, Douglas E. / Salk Institute for Biological Studies
NIH 1993
F32 NS
Characterization of Metabotropic Gluamate Receptor Gene
Vetter, Douglas E. / Salk Institute for Biological Studies
Comments
Be the first to comment on Douglas Vetter's grant